Abattis Bioceuticals (Abattis Bioceuticals) Days Inventory : 384.55 (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Abattis Bioceuticals's Average Total Inventories for the three months ended in Sep. 2019 was $0.21 Mil. Abattis Bioceuticals's Cost of Goods Sold for the three months ended in Sep. 2019 was $0.05 Mil. Hence, Abattis Bioceuticals's Days Inventory for the three months ended in Sep. 2019 was 384.55.

The historical rank and industry rank for Abattis Bioceuticals's Days Inventory or its related term are showing as below:

ATTBF's Days Inventory is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 158.365
* Ranked among companies with meaningful Days Inventory only.

Abattis Bioceuticals's Days Inventory increased from Sep. 2018 (0.00) to Sep. 2019 (384.55). It might indicate that Abattis Bioceuticals's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Abattis Bioceuticals's Inventory Turnover for the three months ended in Sep. 2019 was 0.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Abattis Bioceuticals's Inventory-to-Revenue for the three months ended in Sep. 2019 was 1.21.

Abattis Bioceuticals Days Inventory Historical Data

The historical data trend for Abattis Bioceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Days Inventory Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Days Inventory

Get a 7-Day Free Trial

8,395.00

466.62

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Days Inventory	Get a 7-Day Free Trial															-	-	-	272.58	384.55

Competitive Comparison of Abattis Bioceuticals's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abattis Bioceuticals's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's Days Inventory falls into.

Abattis Bioceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Abattis Bioceuticals's Days Inventory for the fiscal year that ended in Sep. 2019 is calculated as

	Days Inventory (A: Sep. 2019 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Sep. 2018 )	+	Total Inventories (A: Sep. 2019 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2019 )	*	Days in Period
=	( (0.023	+	0.202)	/	2 )	/	0.088	*	365
=	0.1125					/	0.088	*	365
=	466.62

Abattis Bioceuticals's Days Inventory for the quarter that ended in Sep. 2019 is calculated as:

	Days Inventory (Q: Sep. 2019 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2019 )	+	Total Inventories (Q: Sep. 2019 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2019 )	*	Days in Period
=	( (0.211	+	0.202)	/	2 )	/	0.049	*	365 / 4
=	0.2065					/	0.049	*	365 / 4
=	384.55

Abattis Bioceuticals (OTCPK:ATTBF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Abattis Bioceuticals's Inventory Turnover for the three months ended in Sep. 2019 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.049	/	0.2065
	=	0.24

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Abattis Bioceuticals's Inventory to Revenue for the three months ended in Sep. 2019 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.2065	/	0.171
	=	1.21

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Abattis Bioceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.